Escaping Mechanisms of ESKAPE Pathogens from Antibiotics and Their Targeting by Natural Compounds

Overview

Journal Biotechnol Rep (Amst)

Specialty Biotechnology

Date 2022 Jun 10

PMID 35686013

Authors

Ragi Jadimurthy

Shilpa Borehalli Mayegowda

S Chandra Nayak

Chakrabhavi Dhananjaya Mohan

Kanchugarakoppal S Rangappa

Affiliations

Soon will be listed here.

Abstract

The microorganisms that have developed resistance to available therapeutic agents are threatening the globe and multidrug resistance among the bacterial pathogens is becoming a major concern of public health worldwide. Bacteria develop protective mechanisms to counteract the deleterious effects of antibiotics, which may eventually result in loss of growth-inhibitory potential of antibiotics. ESKAPE ( and spp.) pathogens display multidrug resistance and virulence through various mechanisms and it is the need of the hour to discover or design new antibiotics against ESKAPE pathogens. In this article, we have discussed the mechanisms acquired by ESKAPE pathogens to counteract the effect of antibiotics and elaborated on recently discovered secondary metabolites derived from bacteria and plant sources that are endowed with good antibacterial activity towards pathogenic bacteria in general, ESKAPE organisms in particular. Abyssomicin C, allicin, anthracimycin, berberine, biochanin A, caffeic acid, daptomycin, kibdelomycin, piperine, platensimycin, plazomicin, taxifolin, teixobactin, and thymol are the major metabolites whose antibacterial potential have been discussed in this article.

Citing Articles

Discovery of triazole derivatives for biofilm disruption, anti-inflammation and metal ion chelation.

Hong S, Lu H, Tian D, Chang Y, Lu Q, Gao F Front Chem. 2025; 13:1545259.

PMID: 40078565 PMC: 11897050. DOI: 10.3389/fchem.2025.1545259.

Evaluating Anti- Potential of . Extract against Healthcare-Associated Infections in Tertiary Hospitals of Al-Kharj Governorate: An Study.

Khan M, Bari M J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4649-S4654.

PMID: 40061695 PMC: 11888659. DOI: 10.4103/jpbs.jpbs_1253_24.

Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens.

Sakalauskiene G, Malciene L, Stankevicius E, Radzeviciene A Antibiotics (Basel). 2025; 14(1).

PMID: 39858349 PMC: 11762671. DOI: 10.3390/antibiotics14010063.

Antimicrobial Resistance: What Lies Beneath This Complex Phenomenon?.

Sakalauskiene G, Radzeviciene A Diagnostics (Basel). 2024; 14(20).

PMID: 39451642 PMC: 11506786. DOI: 10.3390/diagnostics14202319.

Genomic Analysis of Species Isolated from Patients in United States Hospitals.

Tenover F, Tickler I Antibiotics (Basel). 2024; 13(9).

PMID: 39335038 PMC: 11428811. DOI: 10.3390/antibiotics13090865.

References

Mohan C, Rangappa S, Nayak S, Jadimurthy R, Wang L, Sethi G . Bacteria as a treasure house of secondary metabolites with anticancer potential. Semin Cancer Biol. 2021; 86(Pt 2):998-1013. DOI: 10.1016/j.semcancer.2021.05.006. View

Riedlinger J, Reicke A, Zahner H, Krismer B, Bull A, Maldonado L . Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J Antibiot (Tokyo). 2004; 57(4):271-9. DOI: 10.7164/antibiotics.57.271. View

Nichols D, Cahoon N, Trakhtenberg E, Pham L, Mehta A, Belanger A . Use of ichip for high-throughput in situ cultivation of "uncultivable" microbial species. Appl Environ Microbiol. 2010; 76(8):2445-50. PMC: 2849220. DOI: 10.1128/AEM.01754-09. View

Bush K, Bradford P . Interplay between β-lactamases and new β-lactamase inhibitors. Nat Rev Microbiol. 2019; 17(5):295-306. DOI: 10.1038/s41579-019-0159-8. View

Nargotra A, Sharma S, Koul J, Sangwan P, Khan I, Kumar A . Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors. Eur J Med Chem. 2009; 44(10):4128-35. DOI: 10.1016/j.ejmech.2009.05.004. View

Santajit S, Indrawattana N . Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. Biomed Res Int. 2016; 2016:2475067. PMC: 4871955. DOI: 10.1155/2016/2475067. View

Stompor M . A Review on Sources and Pharmacological Aspects of Sakuranetin. Nutrients. 2020; 12(2). PMC: 7071307. DOI: 10.3390/nu12020513. View

Periasamy H, Iswarya S, Pavithra N, Senthilnathan S, Gnanamani A . In vitro antibacterial activity of plumbagin isolated from Plumbago zeylanica L. against methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol. 2019; 69(1):41-49. DOI: 10.1111/lam.13160. View

Xu Z, Li K, Pan T, Liu J, Li B, Li C . Lonicerin, an anti-algE flavonoid against Pseudomonas aeruginosa virulence screened from Shuanghuanglian formula by molecule docking based strategy. J Ethnopharmacol. 2019; 239:111909. DOI: 10.1016/j.jep.2019.111909. View

10.

Chu M, Zhang M, Liu Y, Kang J, Chu Z, Yin K . Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. Sci Rep. 2016; 6:24748. PMC: 4840435. DOI: 10.1038/srep24748. View

11.

Piddock L . Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006; 19(2):382-402. PMC: 1471989. DOI: 10.1128/CMR.19.2.382-402.2006. View

12.

Uzma F, Mohan C, Hashem A, Konappa N, Rangappa S, Kamath P . Endophytic Fungi-Alternative Sources of Cytotoxic Compounds: A Review. Front Pharmacol. 2018; 9:309. PMC: 5932204. DOI: 10.3389/fphar.2018.00309. View

13.

Lee W, Schaefer K, Qiao Y, Srisuknimit V, Steinmetz H, Muller R . The Mechanism of Action of Lysobactin. J Am Chem Soc. 2015; 138(1):100-3. PMC: 4817722. DOI: 10.1021/jacs.5b11807. View

14.

Guo N, Zhao X, Li W, Shi C, Meng R, Liu Z . The synergy of berberine chloride and totarol against Staphylococcus aureus grown in planktonic and biofilm cultures. J Med Microbiol. 2015; 64(8):891-900. DOI: 10.1099/jmm.0.000106. View

15.

Trombetta D, Castelli F, Sarpietro M, Venuti V, Cristani M, Daniele C . Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother. 2005; 49(6):2474-8. PMC: 1140516. DOI: 10.1128/AAC.49.6.2474-2478.2005. View

16.

Hanski L, Genina N, Uvell H, Malinovskaja K, Gylfe A, Laaksonen T . Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation. PLoS One. 2014; 9(12):e115115. PMC: 4267780. DOI: 10.1371/journal.pone.0115115. View

17.

Singh S, Goetz M, Smith S, Zink D, Polishook J, Onishi R . Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities. Bioorg Med Chem Lett. 2012; 22(23):7127-30. DOI: 10.1016/j.bmcl.2012.09.071. View

18.

Mohan C, Yang M, Rangappa S, Chinnathambi A, Alharbi S, Awad Alahmadi T . 3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma. Biology (Basel). 2022; 11(1). PMC: 8773260. DOI: 10.3390/biology11010029. View

19.

Lee J, Mohan C, Shanmugam M, Rangappa S, Sethi G, Siveen K . Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway. Biochimie. 2020; 175:58-68. DOI: 10.1016/j.biochi.2020.05.006. View

20.

Su M, Qiu L, Deng Y, Ruiz C, Rudolf J, Dong L . Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues against Methicillin-Resistant Staphylococcus aureus in Topical and Systemic Infection Mouse Models. Mol Pharm. 2019; 16(7):3065-3071. PMC: 6763203. DOI: 10.1021/acs.molpharmaceut.9b00293. View